LAS VEGAS, June 15, 2017 (GLOBE NEWSWIRE) -- As THC Therapeutics (OTC:THCT) mentioned in the March 20th press release, we have submitted the second generation dHydronator® for testing with DigiPath Labs, an independent cannabis testing facility. After extensive testing we are now releasing these results which have exceeded all expectations.
View report on our website here - http://thctherapeutics.com/index.php/dhydronator
The dHydronator is a sanitizing herb dryer capable of reducing the drying time of cannabis from 10-14 days down to less than 14 hours. With our built-in, optional SanitiZen® technology we are able to reduce the microbial load from failing cannabis and bring the contaminants down to passing levels. The primary focus of this testing was to determine the drying time, the efficacy of the SanitiZen technology and to determine if the drying and sanitizing process alters the potency of the cannabis. This testing covered over 6 strains and 9 independent tests to confirm the findings. The strains tested were Lucy Diamond, Cotton Candy, Blue Dream, Kings Cut, Pot of Gold, Diablo and Cotton Candy.
Our SanitiZen technology brought the failing TAC (total aerobic count) from over 300,000 down to 78,000. The optimal drying time was determined to be 10-12 hours but may vary by region and ambient humidity. By far the most exciting data from this study is the potency of the cannabis after exposure to the dHydronator. Over the 9 tests and 6 strains we have seen a 4% average increase of THC-A*.
These results have exceeded our expectations and show that we are seeing an average of 4% increase in THC-A*. These findings are surprising even to us, and we couldn’t be more pleased with what the dHydronator can do. These results solidify the functionality of this device, the testing on this device is done and we are ready to bring this product to market. We will continue to look into the application to the home and garden market as well as the agricultural industry.
These results prove the effectiveness of the dHydronator and its viability as a product. We are moving forward to finish the market ready consumer product and begin taking pre-orders as soon as possible.
*See complete results at www.thctherapeutics.com
Comments from our Founder & CEO Brandon Romanek: “I couldn’t be more pleased with the results we’ve received from these tests. Our flagship product (dHydronator), is an amazing and revolutionary device, but what we’re building here is bigger than just one product. THCT has the opportunity to help a lot of people. As the Founder and CEO of THC Therapeutics, my only interest is providing the tools to enhance one's quality of life. There is no publicly traded company like ours, and we will only do that which can help people with their health - mentally, physically and spiritually. I would like to thank our investors and employees for believing in my vision. I look forward to an amazing future for our company.”
About THC Therapeutics:
THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has “Better Health through the Science of Nature” as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.
Forward-Looking Statements Disclosure:
This press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,” “beliefs,” “estimates,” “expects,” “intends,” ” plans,” “seeks,” “will,” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Phone: 702.602.THCC (8422)
Follow Brandon Romanek on Facebook and Twitter:
Twitter @BrandonRomanek
Facebook - Brandon Romanek
Follow THC Therapeutics on Facebook and Twitter:
Twitter @THCTherapeutics
Facebook @THCTherapies